Denied

No. 15-1055

SmithKline Beecham Corporation, dba GlaxoSmithKline, et al. v. King Drug Company of Florence, Inc., et al.

from the United States Court of Appeals for the Third Circuit

See other cases from the Third Circuit.

Docket Entries

Petition DENIED.

Supplemental brief of petitioners SmithKline Beecham Corporation, dba GlaxoSmithKline, et al. filed. (Distributed)

DISTRIBUTED for Conference of November 4, 2016.

Brief amicus curiae of United States filed.

The Solicitor General is invited to file a brief in this case expressing the views of the United States.

DISTRIBUTED for Conference of June 2, 2016.

Reply of petitioners SmithKline Beecham Corporation, dba GlaxoSmithKline, et al. filed.

Brief of respondents King Drug Company of Florence, Inc., et al. in opposition filed.

Brief amicus curiae of Allergan PLC filed.

Brief amici curiae of Washington Legal Foundation, et al. filed.

Brief amicus curiae of Pharmaceutical Research and Manufacturers of America filed.

Brief amicus curiae of Generic Pharmaceutical Association filed.

Brief amicus curiae of National Association of Manufacturers filed.

Order extending time to file response to petition to and including May 2, 2016.

Response Requested . (Due April 1, 2016)

DISTRIBUTED for Conference of March 18, 2016.

Waiver of right of respondents King Drug Company of Florence, Inc., et al. to respond filed.

Petition for a writ of certiorari filed. (Response due March 23, 2016)

Application (15A603) granted by Justice Alito extending the time to file until February 20, 2016.

Application (15A603) to extend further the time from January 21, 2016 to February 20, 2016, submitted to Justice Alito.

Application (15A603) granted by Justice Alito extending the time to file until January 21, 2016.

Application (15A603) to extend the time to file a petition for a writ of certiorari from December 22, 2015 to February 20, 2016, submitted to Justice Alito.

Parties

SmithKline Beecham Corporation, dba GlaxoSmithKline, et al., Petitioner, represented by Jay P. Lefkowitz

King Drug Company of Florence, Inc., et al., Respondent, represented by Bruce E. Gerstein

Amici Curiae

Allergan PLC, Amicus Curiae, represented by J. Mark Gidley

Generic Pharmaceutical Association, Amicus Curiae, represented by Melissa Arbus Sherry

National Association of Manufacturers, Amicus Curiae, represented by Daniel Simon Francis

Pharmaceutical Research and Manufacturers of America, Amicus Curiae, represented by Mark W. Mosier

United States, Amicus Curiae, represented by Ian Heath Gershengorn

Washington Legal Foundation, et al., Amicus Curiae, represented by Richard A. Samp

 
Last updated: March 30, 2017